NCT01722604View on ClinicalTrials.gov

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

PHASE3CompletedINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
GlaucomaOpen Angle or Ocular Hypertension
Interventions
DRUG

brinzolamide 1% ophthalmic suspension

brinzolamide 1% ophthalmic suspension

DRUG

Azopt 1%

Azopt 1%, RLD

Trial Locations (1)

40217

US01, Louisville

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT01722604 - Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt | Biotech Hunter | Biotech Hunter